Dongkook Pharmaceutical Co Ltd banner
D

Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450

Watchlist Manager
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Watchlist
Price: 18 760 KRW 4.8% Market Closed
Market Cap: ₩848.5B

DCF Value

This DCF valuation model was created by Alpha Spread and was last updated on Mar 22, 2026.

Estimated DCF Value of one 086450 stock is 31 037.44 KRW. Compared to the current market price of 18 760 KRW, the stock is Undervalued by 40%.

DCF Value
Base Case
31 037.44 KRW
Undervaluation 40%
DCF Value
Price
D
Worst Case
Base Case
Best Case
31 037.44
DCF Value
Worst Case
Base Case
Best Case
Hide
DCF Value: 31 037.44 KRW

Present Value Calculation

This block is the starting point of the DCF valuation process. It calculates the present value of a company's forecasted cash flows based on selected operating model. Adjust key parameters like discount rate and terminal growth, and alter inputs such as revenue growth and margins to see their impact on valuation.

DCF Model
Base Case Scenario

The present value of cash flows over the next 5 years amounts to 310.9B KRW. The present value of the terminal value is 996.5B KRW. The total present value equals 1.3T KRW.
Forecast Period
Years
Discount Rate
%
Show All DCF Settings
Terminal Growth
%
Hide DCF Settings
Save

DCF Value Calculation

This stage translates the present value into DCF value per share. For firm valuation models, it adjusts present value for debt and assets to derive equity value (skipped if using equity valuation model). Finally, this equity value is divided by the number of shares to determine the DCF value per share.

Present Value to DCF Value
Capital Structure

Present Value 1.3T KRW
+ Cash & Equivalents 49.7B KRW
+ Investments 194.5B KRW
Firm Value 1.6T KRW
- Debt 49.4B KRW
- Minority Interest 98.4B KRW
Equity Value 1.4T KRW
/ Shares Outstanding 45.2m
086450 DCF Value 31 037.44 KRW
Undervalued by 40%

Valuation Analysis

Sensitivity Analysis
DCF Value Sensitivity Analysis

Sensitivity Analysis assesses how changes in key factors like revenue growth, margin, and discount rate affect a stock's DCF value. By visualizing various scenarios, from significant downturns to optimistic growth, this tool helps you understand potential valuation shifts, aiding in risk assessment and strategic decision-making.

DCF Financials
Financials used in DCF Calculation

Revenue
997.5B 1.5T
Operating Income
103.3B 195.3B
FCFF
55.4B 104.8B

What is the DCF value of one 086450 stock?

Estimated DCF Value of one 086450 stock is 31 037.44 KRW. Compared to the current market price of 18 760 KRW, the stock is Undervalued by 40%.

The true DCF Value lies somewhere between the worst-case and best-case scenario values. This is because the future is not predetermined, and the stock's DCF Value is based almost entirely on the future of the company. Knowing the full range of possible stock DCF values gives a complete picture of the investment risks and opportunities.

How was the DCF Value calculated?

1. Present Value Calculation. Utilizing the DCF operating model, Dongkook Pharmaceutical Co Ltd's future cash flows are projected and then discounted using a chosen discount rate to determine its Present Value, which is calculated at 1.3T KRW.

2. DCF Value Calculation. The company's capital structure is employed to derive the total Equity Value from the previously calculated Present Value of the cash flow. This Equity Value, when divided by the total number of outstanding shares, yields the DCF Value of 31 037.44 KRW per share.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett